Marc Blaustein, Chief Operating Officer at Finch Therapeutics Group, Inc. (FNCH), sold 4,619 shares at $0.38 ($2K) on 2023-02-21, disclosed to the SEC on 2023-02-23.
Open-market sale of $2k FNCH by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.